Psyence Biomedical Ltd Stock Total Debt

PBMWW Stock   0.01  0.0006  7.50%   
Psyence Biomedical Ltd fundamentals help investors to digest information that contributes to Psyence Biomedical's financial success or failures. It also enables traders to predict the movement of Psyence Stock. The fundamental analysis module provides a way to measure Psyence Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Psyence Biomedical stock.
Total Debt To Capitalization is likely to drop to -18.82 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Psyence Biomedical Ltd Company Total Debt Analysis

Psyence Biomedical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Psyence Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Psyence Biomedical is extremely important. It helps to project a fair market value of Psyence Stock properly, considering its historical fundamentals such as Total Debt. Since Psyence Biomedical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Psyence Biomedical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Psyence Biomedical's interrelated accounts and indicators.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Psyence Net Debt

Net Debt

10.2 Million

At this time, Psyence Biomedical's Net Debt is fairly stable compared to the past year.
Based on the latest financial disclosure, Psyence Biomedical Ltd has a Total Debt of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The total debt for all United States stocks is 100.0% higher than that of the company.

Psyence Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Psyence Biomedical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Psyence Biomedical could also be used in its relative valuation, which is a method of valuing Psyence Biomedical by comparing valuation metrics of similar companies.
Psyence Biomedical is currently under evaluation in total debt category among its peers.

Psyence Fundamentals

About Psyence Biomedical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Psyence Biomedical Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Psyence Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Psyence Biomedical Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.